These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33262578)

  • 1. Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects.
    Yoo H; Kim Y; Jang IJ; Yu KS; Lee S
    Drug Des Devel Ther; 2020; 14():5179-5187. PubMed ID: 33262578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects.
    Hwang I; Kim Y; Yoo H; Jang IJ; Yu KS; Lee S
    Drug Des Devel Ther; 2020; 14():4493-4502. PubMed ID: 33122892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects.
    Rhee SJ; Choi Y; Lee S; Oh J; Kim SJ; Yoon SH; Cho JY; Yu KS
    Drug Des Devel Ther; 2016; 10():2525-34. PubMed ID: 27570447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No apparent pharmacokinetic interactions were found between henagliflozin: A novel sodium-glucose co-transporter 2 inhibitor and glimepiride in healthy Chinese male subjects.
    Que L; Huang K; Xiang X; Ding Y; Chu N; He Q
    J Clin Pharm Ther; 2022 Aug; 47(8):1225-1231. PubMed ID: 35362180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers.
    Oh ES; Choi C; Kim CO; Kim KH; Kim YN; Kim SJ; Park MS
    J Clin Pharm Ther; 2017 Dec; 42(6):689-694. PubMed ID: 28806472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.
    Gu N; Park MK; Kim TE; Bahng MY; Lim KS; Cho SH; Yoon SH; Cho JY; Jang IJ; Yu KS
    Drug Des Devel Ther; 2014; 8():1709-21. PubMed ID: 25336915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the
    Kim CO; Oh ES; Kim H; Park MS
    Drug Des Devel Ther; 2017; 11():503-512. PubMed ID: 28260863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pharmacokinetic drug interactions between gemigliptin (dipeptidylpeptidase-4 inhibitor) and glimepiride (sulfonylurea) in healthy volunteers.
    Choi HY; Kim YH; Kim MJ; Lee SH; Bang K; Han S; Lim HS; Bae KS
    Drugs R D; 2014 Sep; 14(3):165-76. PubMed ID: 24962635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers.
    Kim D; Choi M; Jin BH; Hong T; Kim CO; Yoo BW; Park MS
    Clin Transl Sci; 2023 Aug; 16(8):1469-1478. PubMed ID: 37282359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glimepiride on the pharmacokinetics of teneligliptin in healthy Korean subjects.
    Park JW; Kim KA; Choi YJ; Yoon SH; Park JY
    J Clin Pharm Ther; 2019 Oct; 44(5):720-725. PubMed ID: 31094010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers.
    Shin Y; Choi C; Oh ES; Kim CO; Park K; Park MS
    Drug Des Devel Ther; 2022; 16():4301-4310. PubMed ID: 36573067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a fixed-dose glimepiride/sustained-release metformin combination.
    Kim KP; Lim KS; Kim BH; Shin HS; Cho JY; Shin SG; Jang IJ; Yu KS
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):142-9. PubMed ID: 22257580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects.
    Kasichayanula S; Liu X; Shyu WC; Zhang W; Pfister M; Griffen SC; Li T; LaCreta FP; Boulton DW
    Diabetes Obes Metab; 2011 Jan; 13(1):47-54. PubMed ID: 21114603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover study.
    Shin KH; Kim SE; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Nov; 33(11):1809-18. PubMed ID: 22036245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
.
    Yoon S; Rhee SJ; Park SI; Yoon SH; Cho JY; Jang IJ; Lee S; Yu KS
    Int J Clin Pharmacol Ther; 2017 Jun; 55(6):533-539. PubMed ID: 28406090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects.
    Rhee SJ; Lee S; Yoon SH; Cho JY; Jang IJ; Yu KS
    Drug Des Devel Ther; 2016; 10():1411-8. PubMed ID: 27110098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Bioequivalency and Pharmacokinetic Parameters for Two Formulations of Glimepiride 1-mg in Chinese Subjects.
    Ju G; Yan K; Xu Y; Chen S; Zheng Z; Qiu W
    Drug Des Devel Ther; 2020; 14():2637-2644. PubMed ID: 32753845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of haemodialysis on the pharmacokinetics and pharmacodynamics of evogliptin.
    Kim B; Im DW; Won H; Sunwoo J; Han SS; Lee H; Kim DK; Oh KH; Joo KW; Kim YS; Cho JY; Lee S; Oh J; Jang IJ; Kim YC
    Diabetes Obes Metab; 2023 Jun; 25(6):1769-1776. PubMed ID: 36852751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects.
    Kim CH; An H; Kim SH; Shin D
    Drug Des Devel Ther; 2017; 11():3461-3469. PubMed ID: 29255347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.